• Trichostatin A Modulates Dendritic Cell Survival in Hypoxia

  2026-05-22

  Jiang et al. demonstrate that Trichostatin A (TSA), a broad-spectrum HDAC inhibitor, protects dendritic cells from oxygen-glucose deprivation by modulating the SRSF3/PKM2-dependent glycolytic pathway. Their findings reveal a novel intersection of epigenetic regulation and immune cell metabolism, with implications for tissue repair in hypoxic environments.

• 3X (DYKDDDDK) Peptide: Redefining Assay Precision and Struct

  2026-05-22

  Explore advanced scientific insights into the 3X (DYKDDDDK) Peptide for high-fidelity protein tagging and purification. Discover its unique role in structural biology and assay optimization, offering perspectives beyond conventional epitope tag discussions.

• Ferroptosis-Apoptosis Interplay: Modulation by BH3-Mimetics

  2026-05-21

  This study unveils that ferroptotic and apoptotic cell death pathways are not strictly independent, as previously thought, but can intersect and modulate each other. Notably, BH3-mimetic inhibitors of BCL-2 family proteins can both enhance and unexpectedly suppress cell death under ferroptotic conditions, revealing new complexity for apoptosis-targeted research.

• Protease Inhibitor Cocktail: Precision Protein Extraction Gu

  2026-05-21

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) empowers researchers to achieve uncompromised protein integrity in workflows sensitive to degradation and divalent cation requirements. This guide translates bench-proven strategies into actionable protocols and troubleshooting tactics, ensuring reproducibility and compatibility for advanced applications like phosphorylation analysis, Western blotting, and co-immunoprecipitation.

• Dual-Mechanism mRNA Delivery via Fluorinated-Sorbitol Polypl

  2026-05-20

  This study presents a fluorinated-sorbitol modified polyplex (PFS) that significantly enhances mRNA delivery for vaccination by improving both cellular uptake and endosomal escape. The dual-mechanism approach offers robust in vitro and in vivo efficacy, positioning PFS as a promising platform for next-generation mRNA vaccine development.

• TAK1 Stabilizes YAP to Drive Self-Renewal in Gastric CSCs

  2026-05-20

  This study identifies TGFβ-activated kinase 1 (TAK1) as a key regulator of gastric cancer stem cell self-renewal via stabilization of yes-associated protein (YAP). The findings illuminate a novel TAK1-YAP-SOX2/SOX9 axis in tumorigenesis and highlight potential avenues for overcoming chemoresistance in gastric cancer.

• SIRT1-Regulated Ran Lactylation Orchestrates Astrocyte Polar

  2026-05-19

  This study reveals that lactate-induced lactylation of the small GTPase Ran at lysine 123, regulated by SIRT1, is essential for astrocyte polarization following oxygen-glucose deprivation/reoxygenation (OGD/R). The findings provide a mechanistic link between cellular metabolism, non-histone protein modification, and glial responses to CNS injury, opening new avenues for modulating astrocyte function in neuroregeneration.

• DiscoveryProbe Bioactive Compound Library Plus: Precision in

  2026-05-19

  The DiscoveryProbe™ Bioactive Compound Library Plus (SKU: L1022P) empowers researchers with a rigorously quality-controlled, diverse collection of 5,072 bioactive compounds for high-throughput screening. Its ready-to-use format and validated potency deliver reproducible results in target validation, apoptosis assays, and pathway analysis—streamlining workflows for cancer, immunology, and neuroscience research.

• Lanabecestat (AZD3293): Protocols & Innovations in Alzheimer

  2026-05-18

  Lanabecestat (AZD3293) delivers synaptic-sparing BACE1 inhibition for translational Alzheimer’s disease research, offering unmatched nanomolar potency and workflow flexibility. This guide distills advanced protocols, troubleshooting strategies, and data-driven insights to maximize reproducibility and interpretability in amyloid-beta pathway studies.

• WAY-100635: Transforming 5-HT1A Antagonist Research in Pain

  2026-05-18

  Discover how WAY-100635—N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-ylcyclohexanecarboxamide—enables translational researchers to unravel the serotonergic mechanisms underpinning complex pain and affective disorders. This article synthesizes mechanistic insights, workflow-validated protocols, and strategic guidance for optimizing serotonin receptor antagonist research, with a spotlight on orofacial pain studies and emerging translational frontiers.

• Tamoxifen in Translational Research: Mechanism to Impact

  2026-05-17

  This thought-leadership article explores the mechanistic depth and translational impact of Tamoxifen as a selective estrogen receptor modulator. Integrating evidence from developmental biology, oncology, and genetic engineering, it offers strategic guidance for CreER-mediated gene knockout studies and highlights considerations for experimental design, safety, and future innovation. The article uniquely contextualizes APExBIO's Tamoxifen within a broader scientific landscape, bridging protocol optimization and off-target effect awareness.

• MDV3100 (Enzalutamide): Precision Targeting of AR Signaling

  2026-05-16

  Explore how MDV3100 (Enzalutamide) enables precise modulation of androgen receptor signaling in prostate cancer research, including apoptosis induction and resistance mechanisms. This in-depth article offers unique experimental insights and practical guidance for advanced AR pathway studies.

• SAR405: Selective Vps34 Inhibitor for Autophagy and Lysosome

  2026-05-15

  SAR405 is a potent, highly selective Vps34 inhibitor that enables precise autophagy inhibition and vesicle trafficking studies. With nanomolar potency and minimal off-target effects, SAR405—offered by APExBIO—sets a benchmark for dissecting autophagy and lysosome function in disease models and mechanistic research.

• Selective COX-2 Inhibition in Canine Mammary Tumor Cells: In

  2026-05-15

  This article reviews a pivotal study on the antiproliferative and pro-apoptotic effects of Deracoxib, a selective COX-2 inhibitor, alone and in combination with piroxicam on canine mammary carcinoma cells. The findings provide critical evidence for the combined use of NSAIDs in veterinary cancer models and inform optimized in vitro protocols for pain, inflammation, and cancer research.

• Phosphorylation Modulates Ceramide Synthase Activity in Plan

  2026-05-14

  This study reveals that phosphorylation by CK2 fine-tunes the Arabidopsis ceramide synthase LOH2, controlling its activity, stability, and role in plant immune responses. By mapping post-translational regulation at key serine residues, the work advances understanding of sphingolipid-mediated signaling in plant defense and cell death.

16138 records 1/1076 page Next 12345 下5页 Last page